BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 20833738)

  • 1. Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.
    Houssiau FA; D'Cruz D; Sangle S; Remy P; Vasconcelos C; Petrovic R; Fiehn C; de Ramon Garrido E; Gilboe IM; Tektonidou M; Blockmans D; Ravelingien I; le Guern V; Depresseux G; Guillevin L; Cervera R;
    Ann Rheum Dis; 2010 Dec; 69(12):2083-9. PubMed ID: 20833738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.
    Contreras G; Tozman E; Nahar N; Metz D
    Lupus; 2005; 14 Suppl 1():s33-8. PubMed ID: 15803929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis.
    Tamirou F; D'Cruz D; Sangle S; Remy P; Vasconcelos C; Fiehn C; Ayala Guttierez Mdel M; Gilboe IM; Tektonidou M; Blockmans D; Ravelingien I; le Guern V; Depresseux G; Guillevin L; Cervera R; Houssiau FA;
    Ann Rheum Dis; 2016 Mar; 75(3):526-31. PubMed ID: 25757867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
    Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM; Sahin S; Kiziltas S; Masatlioglu S; Oguz F; Ergin H
    Ren Fail; 2008; 30(9):865-9. PubMed ID: 18925525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
    Mejía-Vilet JM; Arreola-Guerra JM; Córdova-Sánchez BM; Morales-Buenrostro LE; Uribe-Uribe NO; Correa-Rotter R
    J Rheumatol; 2015 Nov; 42(11):2082-91. PubMed ID: 26373566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
    Prasad N; Kurian J; Agarwal V; Bhadauria D; Behera M; Yacha M; Kushwaha R; Agrawal V; Jain M; Gupta A
    Lupus; 2020 Jul; 29(8):845-853. PubMed ID: 32437258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis.
    Feng L; Deng J; Huo DM; Wu QY; Liao YH
    Nephrology (Carlton); 2013 Feb; 18(2):104-10. PubMed ID: 23113811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
    Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
    Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.
    Chan TM; Tse KC; Tang CS; Mok MY; Li FK;
    J Am Soc Nephrol; 2005 Apr; 16(4):1076-84. PubMed ID: 15728784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial.
    Stoenoiu MS; Aydin S; Tektonidou M; Ravelingien I; le Guern V; Fiehn C; Remy P; Delahousse M; Petera P; Quémeneur T; Vasconcelos C; D'Cruz D; Gilboe IM; Jadoul M; Karras A; Depresseux G; Guillevin L; Cervera R; Cosyns JP; Houssiau FA;
    Nephrol Dial Transplant; 2012 May; 27(5):1924-30. PubMed ID: 22110048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
    Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
    N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
    Dooley MA; Jayne D; Ginzler EM; Isenberg D; Olsen NJ; Wofsy D; Eitner F; Appel GB; Contreras G; Lisk L; Solomons N;
    N Engl J Med; 2011 Nov; 365(20):1886-95. PubMed ID: 22087680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine.
    Fischer-Betz R; Specker C; Brinks R; Aringer M; Schneider M
    Rheumatology (Oxford); 2013 Jun; 52(6):1070-6. PubMed ID: 23382355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up.
    Argolini LM; Frontini G; Elefante E; Saccon F; Binda V; Tani C; Scotti I; Carli L; Gatto M; Esposito C; Gerosa M; Caporali R; Doria A; Messa P; Mosca M; Moroni G
    J Nephrol; 2021 Apr; 34(2):389-398. PubMed ID: 32462476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leflunomide versus azathioprine for maintenance therapy of lupus nephritis: a prospective, multicentre, randomised trial and long-term follow-up.
    Fu Q; Wu C; Dai M; Wang S; Xu J; Dai L; Li Z; He L; Zhu X; Sun L; Lu L; Bao C
    Ann Rheum Dis; 2022 Nov; 81(11):1549-1555. PubMed ID: 35788493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M; Goyal A; Jaryal A; Sharma A; Gupta PK; Ramachandran R; Kumar V; Kohli HS; Sakhuja V; Jha V; Gupta KL
    Kidney Int; 2016 Jan; 89(1):235-42. PubMed ID: 26489028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis.
    Baskin E; Ozen S; Cakar N; Bayrakci US; Demirkaya E; Bakkaloglu A
    Pediatr Nephrol; 2010 Jan; 25(1):111-7. PubMed ID: 19727839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential therapies for proliferative lupus nephritis.
    Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
    N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial.
    Sundel R; Solomons N; Lisk L;
    Lupus; 2012 Nov; 21(13):1433-43. PubMed ID: 22922564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.